Heel Inc. Unveils Reboost Cold and Flu Brand and New Traumeel Packaging at Natural Products Expo West
Albuquerque, NM (PRWEB) March 07, 2013
Heel Inc. a homeopathic pharmaceutical company announces the unveiling of the Reboost cold and flu product line and new packaging for the Traumeel® pain relief product line at Natural Products Expo West. The Reboost product line brings together four of the companys trusted cold, cough and flu products under a single brand that has been specifically designed to speak to the consumer in a retail environment. The redesigned packaging of Traumeel® includes bold, red branding and a space-saving shelf layout beneficial to retailers.
These new options will help retailers better respond to increasing consumer interest in and demand for medicines with natural ingredients, including homeopathic products that provide relief with rare side effects, said Cliff Clive, CEO of Heel Inc. As a trusted name in homeopathic medicines, Heel is committed to meeting the needs of both retailers and consumers by offering medicines with an impressive safety profile.
The Reboost brand provides a suite of medicines for the temporary relief of common cold and flu symptoms. The products have been designed for the retail market with visually-compelling, recognizable branding and packaging that includes consumer-friendly information. The redesigned Traumeel® packaging, with a new vertical orientation, better maximizes shelf space for retailers by taking up less space on the largest selling items (50 g ointment and gel and the 100 g ointment) and allowing retailers dramatic profitability gains per foot of shelf space. The new packaging will also contain a new formula of Traumeel® that has been shown to provide pain relief for ankle sprain that is equivalent to an Rx diclofenac topical.
These changes are set to debut on store shelves beginning in September of 2013. Retailers can learn more by contacting their Heel representative at 1-800-621-7644.
Reboost Cold, Cough and Flu Products
The Reboost line of products includes Nasal Spray (0.68 fluid ounces) for the temporary relief of minor nasal symptoms, Throat Spray (0.68 fluid ounces) for the temporary relief of minor pain from sore throat and pain from canker sores, Tablets (100 ct) for the temporary relief of flu symptoms and Cough Syrup (4.23 fluid ounces) for cough and chest congestion relief. This line of products will replace previous Heel products Nectadyn, Sinusin and Vinceel for the retail marketplace.
Traumeel® Pain Relief Products
Traumeel® is a combination of 12 natural active* ingredients (out of 14 actives) that work together, complementing the bodys natural processes to reduce joint, back and muscle pain, which may lead to improved mobility. For flexibility of use and to maximize the convenience, Traumeel® is available in multiple dosage forms including Traumeel® 50 g Ointment, Traumeel® 100 g Ointment, Traumeel® 50 g Gel, Traumeel® 250 g Gel, Traumeel® Oral Drops 50 ml, Traumeel® 100 ct Tablets and Traumeel® Combo Pack.
About Heel Inc.
Heel is a homeopathic pharmaceutical company that develops, manufactures and distributes medicines based primarily on natural substances. Heel medicines are available through healthcare providers and fine natural product stores throughout the United States. For more information on other Heel products and their use, please visit http://www.heelusa.com.
Follow Heel on Facebook and view Heel Inc.s growing video library on YouTube.
Note: These statements have not been reviewed by the Food and Drug Administration. They are supported by traditional homeopathic principles.
Biologische Heilmittel Heel GmbH. Randomized, Controlled, Multi-center Study on the Effectiveness of Traumeel S (Both Ointment and Gel) in Terms of Pain and Function Compared With a Topical NSAID in Athletes With Acute Ankle Sprain. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000- [cited 2013 Feb 12]. Available from: http://clinicaltrials.gov/show/NCT01066520 NLM Identifier: NCT01066520.
Read the full story at http://www.prweb.com/releases/2013/3/prweb10505110.htm